JAN 02, 2020 8:33 PM PST

The new "tumor-on-a-chip"

In order to mimic the microenvironment of a tumor in the human body, researchers from Kyoto University have developed a device that they are describing as a 'tumor-on-a-chip'. The device is capable of mimicking the biochemical and biomechanical environments of tumors in vitro in order to allow for enhanced testing for potential new anti-cancer drugs. The research was published recently in the journal Biomaterials.

As small as a coin with a 1-millimeter well in its center, the tumor-on-a-chip is meant to mimic structurally as well as chemically a real tumor in the human body. As Science Daily describes, the small well on the chip is surrounded by 100 µm micro-posts, which support the growth of vasculature around the cultured tumor cells – a concept that is seen in human cancer tumors. To put it into simpler terms, blood vessels grow around the tiny posts to create an intertwined 3-D web on the culture.

"This 'perfusable vasculature' allows us to administer nutrients and drugs into the system to mimic the environment in the body," explains Yuji Nashimoto, first author of the study. "This allows us to have a clearer picture of the effectiveness of cancer-treating compounds."

The need for this type of technology is clear, state the researchers. Testing new drugs in cultures is time-consuming and often futile. "Potential compounds are tested using animal models and cells cultured in a dish. However, those results frequently do not transfer over to human biology," adds Nashimoto, of Tohoku University. "Furthermore, cells on a dish lack the three-dimensional structure and blood vessels, or vasculature, that keep it alive. So, we came up with a plan to construct a device that solves these issues."

Scientists develop "tumor-on-a-chip" to mimic a tumor's microenvironment. Photo: Pixabay

The findings from the researchers’ investigations show that this type of vasculature was successful in maintaining tumor cells’ healthy and proliferating so that anti-tumor drugs could be tested in more natural environs. They also found that drugs tested were most potent under flow conditions of the vasculature, proving, says lead researcher Ryuji Yokokawa, “the importance of blood flow in the vasculature when screening for drugs.”

The team of scientists hopes that their work will advance ongoing and future cancer-fighting drug trials. “Due to its size and utility, we hope the new device can expedite the tests on the countless number of potential new drugs,” concludes Yokokawa. “While many questions remain, we are happy to have developed this device and have shown that three-dimensional perfused cell culture is vital for the next step in drug discovery."

Sources: Science Daily, Biomaterials

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 18, 2021
Cancer
New guidelines change screening age for colorectal cancer to 45
MAY 18, 2021
New guidelines change screening age for colorectal cancer to 45
Following new guideline changes from the U.S. Preventive Services Task Force (USPSTF), individuals with an average risk ...
MAY 19, 2021
Cancer
How does environmental quality affect prostate cancer aggressiveness?
MAY 19, 2021
How does environmental quality affect prostate cancer aggressiveness?
A study from researchers at the University of Illinois Chicago investigates the link between environmental quality and p ...
JUN 23, 2021
Cancer
Military universal health system boasts higher survival rates for colon cancer patients
JUN 23, 2021
Military universal health system boasts higher survival rates for colon cancer patients
New results published in the American Association for Cancer Research journal Cancer Epidemiology, Biomarkers & Prev ...
JUL 08, 2021
Genetics & Genomics
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
JUL 08, 2021
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
Children with Down syndrome have a significantly higher likelihood myeloid leukemia occurring in the first five years of ...
AUG 13, 2021
Cancer
Ultrasound Triggers Immunotherapy to Destroy Tumors
AUG 13, 2021
Ultrasound Triggers Immunotherapy to Destroy Tumors
An immunotherapy engineered to be triggered by ultrasound beams significantly slows the growth of cancerous tumors in mi ...
AUG 25, 2021
Cell & Molecular Biology
Sino Biological's Listing on the Shenzhen Stock Exchange
AUG 25, 2021
Sino Biological's Listing on the Shenzhen Stock Exchange
China, August 16, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biot ...
Loading Comments...